We are live on ! Find out more
CBIO

Crescent Biopharma

80 hedge funds and large institutions have $535M invested in Crescent Biopharma in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 9

38% more funds holding

Funds holding: 5880 (+22)

32% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 19

29% more capital invested

Capital invested by funds: $416M → $535M (+$119M)

0.02% more ownership

Funds ownership: 0.91%0.93% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

46% less call options, than puts

Call options by funds: $2.14M | Put options by funds: $3.96M

Holders
80
Holders Change
+22
Holders Change %
+37.93%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
31
Increased
25
Reduced
19
Closed
9
Calls
$2.14M
Puts
$3.96M
Net Calls
-$1.81M
Net Calls Change
-$1.62M